Oct 20 (Reuters) – Natera Inc: * NATERA INC: SUCCESSFUL IMVIGOR011 TRIAL ACHIEVES 41% IMPROVEMENT IN OVERALL SURVIVAL FOR BLADDER CANCER PATIENTS Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
STOCKHOLM, Oct 20 (Reuters) - Swedish metal-cutting and mining equipment maker Sandvik reported a larger-than-expected…
BEIJING (Reuters) -A group of 55 Chinese iPhone and iPad users filed a complaint with…
PRAGUE, Oct 20 (Reuters) - The forint drifted off a 16-month high versus the euro…
BEIJING (Reuters) -A group of 55 Chinese iPhone and iPad users filed a complaint with…
ROME, Oct 20 (Reuters) - Italian aerospace and defence group Leonardo is scheduled to hold…
. SPORTS DAILY OUTLOOK - MONDAY OCTOBER 20, 2025 . EXPECTED: . SOCCER-CHAMPIONS-NEW-SLB/PREVIEW - Benfica…